Amneal to Report Second Quarter 2026 Results on July 30, 2026
Amneal (NASDAQ:AMRX) will report second quarter 2026 financial results on Thursday, July 30, 2026, before the market opens.
Rhea-AI Summary
Amneal (NASDAQ:AMRX) will report second quarter 2026 financial results on Thursday, July 30, 2026, before the market opens. The company will host an audio webcast at 8:30 a.m. ET, accessible via the Investor Relations section of its website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – AMRX
In the Jul 10 session, AMRX declined 0.06%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Quarter reported
- second quarter 2026
- Period for upcoming financial results
- Earnings release date
- July 30, 2026
- Results to be reported before market open
- Webcast time
- 8:30 a.m. ET
- Scheduled start of earnings audio webcast
- U.S. dial-in number
- 1 (833) 461-5787
- Phone access for earnings call
- Access code
- 901153095
- Conference call access code
Previous Earnings date Reports
-
Set timing for first quarter 2026 results and webcast logistics.
-
Announced date and time for Q4 and full-year 2025 results call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRIDGEWATER, N.J., July 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it will report second quarter 2026 financial results on Thursday, July 30, 2026, before market open. The Company will host an audio webcast at 8:30 a.m. ET.
The financial results and live webcast will be available through the Investor Relations section of the Company's website at investors.amneal.com. Individuals may register for the webcast by clicking here. To access the call by phone, dial 1 (833) 461-5787 (U.S.) or view a list of toll-free international numbers here. The access code for is 901153095. A replay of the webcast will be available shortly after the call.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, New Jersey, is a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines. Founded in 2002 by brothers and co-CEOs Chirag and Chintu Patel, Amneal was built on the belief that innovation only matters if it’s accessible. Today, Amneal has a diverse and growing portfolio of approximately 300 complex, specialty and biosimilar medicines, delivering over 160 million prescriptions each year, primarily in the United States. Our Affordable Medicines segment spans retail, injectable, and biosimilar products. Our Specialty segment provides branded treatments in neurology, including Parkinson’s disease and migraine, and endocrinology. Our AvKARE segment distributes pharmaceuticals and medical products to U.S. federal, retail, and institutional customers. For more information, visit and follow us on LinkedIn.
Investor Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.